Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119153832 | 11915383 | 2 | F | 20000915 | 20160826 | 20160114 | 20160826 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-10969699 | BRISTOL MYERS SQUIBB | 0.00 | DY | M | Y | 3.59000 | KG | 20160826 | OT | US | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119153832 | 11915383 | 1 | PS | ZERIT | STAVUDINE | 1 | Transplacental | 80 MG, UNK | U | 20412 | 80 | MG | |||||||
| 119153832 | 11915383 | 2 | SS | ZERIT | STAVUDINE | 1 | Oral | 7.4 MG, QD | Y | 0 | 7.4 | MG | ORAL SOLUTION | QD | |||||
| 119153832 | 11915383 | 3 | SS | EPIVIR | LAMIVUDINE | 1 | Transplacental | 300 MG, QD | 75600 | MG | U | 0 | 300 | MG | QD | ||||
| 119153832 | 11915383 | 4 | SS | NORVIR | RITONAVIR | 1 | Transplacental | 200 MG, QD | 50400 | MG | U | 0 | 200 | MG | QD | ||||
| 119153832 | 11915383 | 5 | SS | INVIRASE | SAQUINAVIR MESYLATE | 1 | Transplacental | 1600 MG, QD | 403200 | MG | U | 0 | 1600 | MG | QD | ||||
| 119153832 | 11915383 | 6 | SS | RETROVIR | ZIDOVUDINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 119153832 | 11915383 | 7 | C | SPASFON | PHLOROGLUCINOL | 1 | Transplacental | U | 0 | ||||||||||
| 119153832 | 11915383 | 8 | C | I RON | FERROUS FUMARATE | 1 | Transplacental | U | 0 | ||||||||||
| 119153832 | 11915383 | 9 | C | ZOVIRAX | ACYCLOVIR | 1 | Transplacental | U | 0 | ||||||||||
| 119153832 | 11915383 | 10 | C | CLAMOXYL | AMOXICILLINCLAVULANIC ACID | 1 | Transplacental | U | 0 | ||||||||||
| 119153832 | 11915383 | 11 | C | NETROMICINE | NETILMICIN SULFATE | 1 | Transplacental | U | 0 | ||||||||||
| 119153832 | 11915383 | 12 | C | PRO-DAFALGAN | 2 | Transplacental | U | 0 | |||||||||||
| 119153832 | 11915383 | 13 | C | GYNO PEVARYL | ECONAZOLE NITRATE | 1 | Transplacental | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119153832 | 11915383 | 1 | Product used for unknown indication |
| 119153832 | 11915383 | 2 | Antiretroviral therapy |
| 119153832 | 11915383 | 3 | Product used for unknown indication |
| 119153832 | 11915383 | 4 | Product used for unknown indication |
| 119153832 | 11915383 | 5 | Product used for unknown indication |
| 119153832 | 11915383 | 6 | Product used for unknown indication |
| 119153832 | 11915383 | 7 | Product used for unknown indication |
| 119153832 | 11915383 | 8 | Product used for unknown indication |
| 119153832 | 11915383 | 9 | Product used for unknown indication |
| 119153832 | 11915383 | 10 | Product used for unknown indication |
| 119153832 | 11915383 | 11 | Product used for unknown indication |
| 119153832 | 11915383 | 12 | Product used for unknown indication |
| 119153832 | 11915383 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119153832 | 11915383 | HO |
| 119153832 | 11915383 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119153832 | 11915383 | Blood creatine phosphokinase increased | |
| 119153832 | 11915383 | Blood lactic acid increased | |
| 119153832 | 11915383 | Blood pyruvic acid increased | |
| 119153832 | 11915383 | Foetal exposure during pregnancy | |
| 119153832 | 11915383 | Growth retardation | |
| 119153832 | 11915383 | Haemangioma | |
| 119153832 | 11915383 | Hypertriglyceridaemia | |
| 119153832 | 11915383 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119153832 | 11915383 | 1 | 20000106 | 20000915 | 0 | |
| 119153832 | 11915383 | 2 | 20000915 | 20001103 | 0 | |
| 119153832 | 11915383 | 3 | 20000106 | 20000915 | 0 | |
| 119153832 | 11915383 | 4 | 20000106 | 20000915 | 0 | |
| 119153832 | 11915383 | 5 | 20000106 | 20000915 | 0 | |
| 119153832 | 11915383 | 6 | 20000915 | 20000915 | 0 |